Stripping Massage After Thoracoscopy

Pain Relief Following Stripping Massage for Rhomboid Myofascial Trigger Points After Thoracoscopic Surgery

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04716816

Acronym

SMAT

Enrollment

Registered

2021-01-20

Start date

2021-01-17

Completion date

2021-12-31

Last updated

2021-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Keywords

Chest pain; Stripping massage; thoracoscopy; trigger points

Brief summary

This study investigated the effects of stripping massage (SM) on myofascial trigger points in the rhomboid after thoracoscopic surgery.

Detailed description

This study investigated the effects of stripping massage (SM) on myofascial trigger points in the rhomboid after thoracoscopic surgery. Sixty patients with chest pain after thoracoscopic surgery were randomized divided into two equal groups (A and B). Group A (n = 100) received conventional analgesics. Group B (n = 100) received SM twice daily in the active trigger points of the rhomboid for two weeks. The visual analogue scale, a pressure algometer, will be used to evaluate patients' pre- and post-treatment statuses. This study will compare differences between the current traditional method (using analgesics) and the SM for rhomboid myofascial trigger points for post-thoracoscopic chest pain, and analyze the variables generated by the two different methods including demand time of analgesics, acceptance, and differences of visual analogue scale. The results of the study will use scientific data to prove which way is a good way to take into account of the relief of patient's chest pain.

Interventions

PROCEDUREStripping massage

Stripping massage for rhomboid myofascial trigger points

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Masking description

treatment method and treatment group

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Chest pain with visual analogue scale larger than 3 after thoracoscopic surgery

Exclusion criteria

* bleeding tendency

Design outcomes

Primary

Measure	Time frame	Description
Change From Baseline in Pain Scores on the Visual Analog Scale	baseline, 3 days, one weeks, two weeks, one month	differences of visual analogue scale. (score from mild 0 to severe 10)

Secondary

Measure	Time frame	Description
demand time of analgesics	baseline, 3 days, one weeks, two weeks, one month	demand time of analgesics after thoracoscopic surgery

Countries

Taiwan

Contacts

Primary ContactPei-Ming Huang, MD, Ph.D

e370089@gmail.com+886-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026